MILLENNIUM MANAGEMENT LLC

Position in ANTX — AN2 Therapeutics, Inc.

CIK 1273087 NEW YORK, NY

Position in ANTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$11,222,469

+$3,621,513 QoQ

Shares Held

2,318,692

+4.3% QoQ

Ownership

6.14%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 66 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,596,705,485 across 322 Biotechnology names. ANTX ranks #99 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	468,410	$232,673,299
2	INSM	INSMED Inc	2,048,005	$218,358,293
3	APGE	Apogee Therapeutics, Inc.	1,491,404	$197,954,052
4	JAZZ	Jazz Pharmaceuticals plc	763,880	$184,072,163
5	ONC	BeOne Medicines Ltd.	543,323	$154,830,755
6	AXSM	Axsome Therapeutics, Inc.	556,088	$136,113,659
7	BMRN	Biomarin Pharmaceutical Inc	2,071,816	$118,549,311
8	REGN	Regeneron Pharmaceuticals, Inc.	165,120	$102,958,924

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,222,469	2,318,692	+4.3%	Shares	Sole	2026-08-14
2026-03-31	$7,600,956	2,222,502	+2222.8%	Shares	Sole	2026-05-15
2025-12-31	$109,078	95,683	+91.2%	Shares	Sole	2026-02-17
2025-03-31	$68,051	50,038	-76.1%	Shares	Sole	2025-05-15
2024-12-31	$288,925	209,366	-47.4%	Shares	Sole	2025-02-14
2024-09-30	$425,779	397,925	-24.4%	Shares	Sole	2024-11-14
2024-06-30	$1,131,656	526,352	+443.1%	Shares	Sole	2024-08-14
2024-03-31	$314,970	96,914	+144.3%	Shares	Sole	2024-05-15
2023-12-31	$812,920	39,674	+63.7%	Shares	Sole	2024-02-14
2023-06-30	$206,057	24,242	-67.3%	Shares	Sole	2023-08-14
2022-03-31	$1,118,766	74,238	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.